Histological and functional evaluation of experimental spinal cord injury: Evidence of a stepwise response to graded compression

Brain Research

Volumn 729, Issue 1, 1996, Pages 90-101

  Gruner, John A ^a   Yee, Andrew K ^a   Blight, Andrew R ^b  

^a CEPHALON INC   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Functional recovery; Reticulospinal; Secondary loss; Segmental reflex

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; THORACIC SPINAL CORD;

EID: 0030570810     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00366-6     Document Type: Article

References (45)

1. [1] Anderson, D.K., Braughler, J.M., Hall, E.D., Waters, T.R., McCall, J.M. and Means, E.D., Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury, J. Neurosurg., 69 (1988) 562-567.
2. [2] Basso, D.M., Beattie, M.S. and Bresnahan, J.C., Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device, Exp. Neurol. (1995) (submitted).
3. [3] Basso, D.M., Beattie, M.S. and Bresnahan, J.C., A sensitive and reliable locomotor rating scale for open field testing in rats, J. Neurotrauma, 12 (1995) 1-21. *
4. [4] Beattie, M.S. and Bresnahan, J.C., Longitudinal assessment of recovery of locomotor function in rats after feedback-controlled spinal cord impact lesions. In M. Brown and M.E. Goldberger (Eds.), Criteria for Assessing Recovery of Function: Behavioral Methods, American Paralysis Assoc. Press, Springfield, NJ, 1989, pp. 16-25.
5. [5] Behrmann, D.L., Bresnahan, J.C. and Beattie, M.S., A comparison of YM-14673, U-50488H and nalmefene after spinal cord injury in the rat, Exp. Neurol., 119 (1993) 258-267.
6. [6] Behrmann, D.L., Bresnahan, J.C. and Beattie, M.S., Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673, Exp. Neurol., 126 (1994) 61-75.
7. [7] Behrmann, D.L., Bresnahan, J.C., Beattie, M.S. and Shah, B.R., Spinal cord injury produced by consistent mechanical displacement of the cord in rats: Behavioral and histologic analysis, J. Neurotrauma, 9 (1992) 197-217.
8. [8] Blight, A.R., Cellular morphology of chronic spinal cord injury in the cat: Analysis of myelinated axons by line-sampling., Neuroscience, 10 (1983) 521-543.
9. [9] Blight, A.R., Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioral evidence of delayed secondary pathology, J. Neurol. Sci., 103 (1991) 156-171.
10. [10] Blight, A.R., Remyelination, revascularization and recovery of function in experimental spinal cord injury. In F.J. Seil (Ed.), Adv. Neurology, Vol. 59, Raven Press, New York, 1993, pp. 91-104.
11. [11] Blight, A.R., Cohen, T.I., Saito, K. and Heyes, M., Quinolinic acid accumulation and functional deficits following experimental spinal cord injury, Brain, 118 (1995) 735-752.
12. [12] Blight, A.R., Saito, K. and Heyes, M.P., Increased levels of the excitotoxin quinolinic acid in spinal cord following contusion injury, Brain Res., 632 (1993) 314-6.
13. [13] Blight, A.R. and Young, W., Axonal morphometric correlates of evoked potentials in experimental spinal cord injury, In S.K. Salzman (Ed.), Preventing Intraoperative Neural Injuries, Humana Press Inc., Baltimore, 1990, pp. 87-113.
14. [14] Bracken, M.B., Shepard, J.J., Collins, W.F., Holford, T.R., Young, W., Baskin, D.S., Eisenberg, H.M., Flamm, E. et al., Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data, J. Neurosurg., 76 (1992) 23-31.
15. [15] Braughler, J.M., Hall, E.D., Means, E.D., Waters, T.R. and Anderson, D. K., Evaluation of an intensive methyulprednisolone sodium succinate dosing regimen in experimental spinal cord injury, J. Neurosurg., 67 (1987) 102-105.
16. [16] Bresnahan, J.C., Beattie, M.S., Stokes, B.T. and Conway, K.M., Three-dimensional computer-assisted analysis of graded contusion lesions in the spinal cord of the rat, J. Neurotrauma, 8 (1991) 91-101.
17. [17] Constantini, S. and Young, W., The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats, J Neurosurg., 80 (1994) 97-111.
18. [18] D'Angelo, C.M., The H-reflex in experimental spinal cord trauma, J. Neurosurg., 39 (1973) 209-213.
19. [19] Faden, A.I., Lemke, M., Simon, R.P. and Noble, L.J., N-methyl-D-aspartate antagonist MK801 improves outcome following traumatic spinal cord injury in rats: Behavioral, anatomic, and neurochemical studies, J. Neurotrauma, 5 (1988) 33-45.
20. [20] Faden, A.I. and Salzman, S.K., Experimental pharmacology. In S.K. Salzman and A.I. Faden (Eds.), The Neurobiology of Central Nervous System Trauma, Oxford University Press, New York, 1994, pp. 227-244.
21. [21] Ford, R.W.J., A reproducible spinal cord injury model in the cat, J. Neurosurg., 59 (1983) 268-275.
22. [22] Grissom, T.E., Mitzel, H.C., Bunegin, L. and Albin, M.S., The effect of anesthetics on neurologic outcome during the recovery period of spinal cord injury in rats, Anesth. Analg., 79 (1994) 66-74.
23. [23] Gruner, J.A., A monitored contusion model of spinal cord injury in the rat, J. Neurotrauma, 9 (1992) 123-126.
24. [24] Gruner, J.A. and Kersun, J.M., Assessment of functional recovery after spinal cord injury in rats by reticulospinal-mediated motor evoked responses. In W.J. Levy, R.Q. Cracco, A.T. Barker and J.C. Rothwell (Eds.), Magnetic Motor Stimulation: Basic Principles and Clinical Experience, Electroencephalogr. Clin. Neurophysiol. Suppl. 43, Elsevier, Amsterdam, 1991, pp. 293-307.
25. [25] Gruner, J.A., Wade, C.K., Menna, G. and Stokes, B.T., Myoelectric evoked potentials versus locomotor recovery in chronic spinal cord injured rats, J. Neurotrauma, 10 (1993) 327-347.
26. [26] Gruner, J.A. and Yee, A.K., Motor evoked potentials following graded spinal cord compression injury in rats: enhancement with 4-aminopyridine in preparation.
27. [27] Harris, R.M., Little, J.W. and Goldstein, B., Spared descending pathways mediate locomotor recovery after subtotal spinal cord injury, Neurosci. Lett., 180 (1994) 37-40.
28. [28] Hashimoto, T. and Fukuda, N., New spinal cord injury model produced by spinal cord compression in the rat, J. Pharmacol. Methods, 23 (1990) 203-212.
29. [29] Holtz, A., Nystrom, B. and Gerdin, B., Relation between spinal cord blood flow and functional recovery after blocking weight-induced spinal cord injury in rats, Neurosurgery, 26 (1990) 952-957.
30. [30] Kerasidis, H., Wrathall, J.R. and Gale, K., Behavioral assessment of functional deficit in rats with contusive spinal cord injury, J. Neurosci. Methods, 20 (1987) 167-179.
31. [31] Koyanagi, I., Tator, C.H. and Theriault, E., Silicone rubber microangiography of acute spinal cord injury in the rat, Neurosurgery, 32 (1993) 260-268.
32. [32] Means, E.D., Anderson, D., Waters, T. and Kalaf, L., Effect of methylprednisolone in compression trauma to the feline spinal cord, J. Neurosurg., 55 (1981) 200-208.
33. [33] Midha, R., Fehlings, M.G., Tator, C.H., Saint-Cyr, J.A. and Guha, A., Assessment of spinal cord injury by counting corticospinal and rubrospinal neurons, Brain Res., 410 (1987) 299-308.
34. [34] Murray, M. and Goldberger, M.E., Restitution of function and collateral sprouting in the cat spinal cord: The partially hemisected animal, J. Comp. Neurol., 158 (1974) 19-36.
35. [35] Noble, L.J. and Wrathall, J.R., Correlative analyses of lesion development and functional status after graded spinal cord contusive injuries in the rat, Exp. Neurol., 103 (1989) 34-40.
36. [36] Popovich, P.G., Reinhard, J., Jr., Flanagan, E.M. and Stokes, B.T., Elevation of the neurotoxin quinolinic acid occurs following spinal cord trauma, Brain Res., 633 (1994) 348-352.
37. [37] Precht, W., Vestibular system. In A.C. Guyton and C.C. Hunt (Eds.), MTP International Review of Sciences, Neurophysiology, Vol. 3, Butterworths University Park Press, Baltimore, 1975, pp. 81-149.
38. [38] Puniak, M.A., Freeman, G.M., Agresta, C.A., Newkirk, L.V., Barone, C. A. and Salzman, S.K., Comparison of a serotonin antagonist, opoid antagonist, and TRH analog for the acute treatment of experimental spinal trauma, J. Neurotrauma, 8 (1992) 193-203.
39. [39] Rivlin, A.S. and Tator, C.H., Effects of duration of acute spinal cord compression in a new acute cord injury model in the rat, Surg. Neurol., 10 (1978) 39-43.
40. [40] Saruhashi, Y. and Young, W., Effect of mianserin on locomotory function after thoracic spinal cord hemisection in rats, Exp. Neurol., 129 (1994) 207-216.
41. [41] Schramm, J., Shigeno, T. and Brock, M., Clinical signs and evoked response alterations associated with chronic experimental cord compression, J. Neurosurg., 58 (1983) 734-741.
42. [42] Tator, C.H., Ischemia as a secondary neural injury. In S.K. Salzman and A.I. Faden (Eds.), The Neurobiology of Central Nervous System Trauma, Oxford University Press, New York, 1994, pp. 209-215.
43. [43] Wrathall, J.R., Pettegrew, R.K. and Harvey, F., Spinal cord contusion in the rat: production of graded, reproducible, injury groups, Exp. Neurol., 88 (1985) 108-122.
44. [44] Young, W., Blood flow, metabolic and neurophysiological mechanisms in spinal cord injury. In D.P. Becker and J.T. Povlishock (Eds.), CNS Trauma Status Report, NIH, NINCDS/William Byrd Press, Bethesda, MD, 1985, pp. 463-473.
45. [45] Young, W., Strategies for the development of new and better pharmacological treatments for acute spinal cord injury, Adv. Neurol., 59 (1993) 249-256.